findmyKOL

Yvonne Ou, MD

Enriched profile

Professor of Ophthalmology; Dr. & Mrs. Stacy R. Mettier, Jr. Endowed Chair in Ophthalmology · University of California, San Francisco (UCSF)

ORCIDNPI
Region🇺🇸 Durham, NC · Southeast · United StatesSpecialtyOphthalmologyFocusGlaucoma
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Yvonne Ou is Professor of Ophthalmology; Dr. & Mrs. Stacy R. Mettier, Jr. Endowed Chair in Ophthalmology at University of California, San Francisco (UCSF). OpenAlex indexes 142 publications with 1,963 citations (h-index 24); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 25 Aug 2026

Overview

Updated 27 Aug 2026

Yvonne Ou, MD, is Professor of Ophthalmology at University of California, San Francisco (UCSF), Department of Ophthalmology. The public record shows 142 publications with 1,963 citations (h-index 24), centered on Glaucoma. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 5 companies.

  • Most recent indexed publication: 2023 · Clinical & experimental ophthalmology
  • Top research focus: Glaucoma
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 5 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Glaucoma1 trialComa1 trial

Research focus

OpenAlex concept fingerprint
Glaucoma

Works with

trial sponsors and companies reporting payments
Alcon Vision LLCClinical trialsIndustry payments14Sight Sciences, Inc.Clinical trialsIndustry payments2University of California, San FranciscoClinical trials2Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
142publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

1,963citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
5companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    88.9%
    Prostaglandin Analog34%
    Latanoprost71%Tafluprost18%Lumigan6%Travoprost6%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor30.6%
    Dorzolamide-Timolol71%Dorzolamide Hcl13%Simbrinza13%Brinzolamide3%
    Part D<11 patients
  • Cardiovascular

    8.5%
    Beta blocker8.5%
    Timolol Maleate100%
    Part D<11 patients
  • Nervous system

    1.1%
    Cholinergic Receptor Agonist1.1%
    Pilocarpine Hcl100%
    Part D<11 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)66% facility · 34% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/yvonne-ou-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Other

    glaucoma.org/video/glaucoma-research-and-the-path-to-a-cure-dr-yvonne-ou-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucoma.org
  • X / Twitter

    x.com/GlaucomaOrg/status/709450879250726912

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • M.D.

    Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • Board Certified

    American Board of Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsfhealth.org

Editorial & leadership roles

journal and society appointments
  • Co-Director

    UCSF Glaucoma Division

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsfhealth.org
  • Vice Chair for Postgraduate Education

    UCSF Department of Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsfhealth.org
  • Editorial Board Member

    Ophthalmology Glaucoma (Elsevier journal)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journals.elsevier.com

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.